... to create asset value through best-in-class strategy and execution.
The requirements for success in today’s biopharmaceutical environment are the right assets, strategy, and business tools for execution:
- The ability to identify, navigate, and close transactions in a deal market dominated by a small number of highly selective buyers evaluating 1,000's of opportunities per year
- Charting a clinical and commercial roadmap with changing health policy, reimbursement, pricing and competitive pressures
- Identifying and framing the right strategic alternatives and business models that can attract capital in today’s financing market
The few winners in this environment will have a thoughtful understanding of their firm's strategic alternatives, solid deal execution informed by rigorous analysis, and a robust, integrated development and commercialization plan.